Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary Adenosine for Myocardial Protection in STEMI Patients Undergoing Primary Angioplasty
NCT00781404Phase 3Completed
- Start
- Oct 2008
- Primary completion
- May 2012
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ST elevation myocardial infarction (STEMI) comparing Adenosine with Placebo (2 arms). Primary endpoint: Infarct size measured by MRI. Started Oct 2008; status: completed.
02
Drugs
adenosine
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00781404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00781404.